Advisory Advocates’s Linde LIN Stock Holding History

Advisory Advocates’s Portfolio LIN Stock Details LIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$263K	Sell	506 -1	-0.2%	-$506	0.23%	148
2026 Q1	$251K	Sell	507 -22	-4%	-$10.4K	0.26%	133
2025 Q4	$226K	Buy	+529	New	+$227K	0.22%	139

Other funds holding LIN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Advisory Advocates's LIN Position: Q2 2026 in Review

Advisory Advocates reduced its Linde (LIN) stake by 0.2% in Q2 2026, selling an estimated $506 and leaving 506 shares worth $263K. The position accounts for 0.23% of the portfolio, ranked #148.

Advisory Advocates first reported a position in LIN in Q4 2025 and has held it in 3 quarters since. 2,251 funds tracked by Wall St. Rank hold LIN as of Q2 2026.

Advisory Advocates held 506 shares of Linde worth $263K as of Q2 2026.
Advisory Advocates sold 1 Linde share in Q2 2026, an estimated $506.
Linde made up 0.23% of Advisory Advocates's portfolio in Q2 2026, its #148 holding.
Advisory Advocates first reported a position in Linde in Q4 2025 and has held it in 3 quarters since.
2,251 funds tracked by Wall St. Rank held Linde as of Q2 2026.

Based on Advisory Advocates's 13F filing for Q2 2026, filed 10 Aug 2026.